MiNK Therapeutics, Inc. (INKT) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Mink Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.218 Good morning and welcome to Mink Therapeutics' second quarter 2025 conference 00:00:05.218 -- 00:00:10.826 call and webcast. All participants will be in a listen-only mode until the question 00:00:10.826 -- 00:00:15.693 and answer session. Please note that this event is being recorded. 00:00:15.693 -- 00:00:20.099 If anyone has any objections, you may disconnect at this time. 00:00:20.099 -- 00:00:24.745 I would now like to turn the conference over to Zach Arman from Mink's Investor Relations. 00:00:24.745 -- 00:00:27.588 Zach, please go ahead. 00:00:27.588 -- 00:00:30.771 Thank you, Operator, and thank you all for joining us today. 00:00:30.771 -- 00:00:35.655 Today's call is being webcast and will be available on our website for replay. 00:00:35.655 -- 00:00:39.518 I'd like to remind you that this call will include forward-looking statements, including 00:00:39.518 -- 00:00:44.423 those related to our clinical development, regulatory and commercial plans, timelines 00:00:44.423 -- 00:00:47.846 for data release, and partnership opportunities. 00:00:47.846 -- 00:00:51.089 These statements are subject to risks and uncertainties. 00:00:51.089 -- 00:00:55.513 Please refer to our SEC filings available on our website for a detailed description of 00:00:55.513 -- 00:00:57.322 these risks. 00:00:57.322 -- 00:01:02.029 Joining me today are Dr. Jennifer Buell, President and Chief Executive Officer, and Christine 00:01:02.029 -- 00:01:05.654 Klaskin, Principal Financial and Accounting Officer. 00:01:05.654 -- 00:01:07.577 Now, I'd like to turn the call over to Dr. 00:01:07.577 -- 00:01:11.520 Buell to highlight our progress from this quarter. 00:01:11.623 -- 00:01:13.906 Thank you, Zach, and thank you all for joining us today. 00:01:13.906 -...